Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , today announced the completion of patient enrollment in a phase III clinical trial of ADCETRIS for post-transplant …
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release … – Sacramento Bee
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release …Sacramento BeeDeveloped by Astellas, tacrolimus extended release capsules are a once daily formulation of calcineurin-inhibitor immunosuppressant tacrolimus. The NDA submissi…
Barfi's success is humbling; response was unexpected: Basu – Moneycontrol.com
IBTimes IndiaBarfi's success is humbling; response was unexpected: BasuMoneycontrol.com… Basu's latest film Barfi has charmed both filmgoers and critics alike. Combining modern outlook and cinematic aesthetics with a traditional Indian sensib…
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour … – pharmabiz.com
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour …pharmabiz.comPatients had relapsed following a median of five prior therapies (range 2-15); 44% had failed prior stem cell transplant and 52% were rituximab refractory….
Astellas seeks FDA approval for tacrolimus tablets – Pharmaceutical Business Review
Astellas seeks FDA approval for tacrolimus tabletsPharmaceutical Business ReviewAstellas Pharma US has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the…
Bosses less likely to suffer heart attack: study – Business Standard
Bosses less likely to suffer heart attack: studyBusiness Standard… likely to suffer heart attack: study. Press Trust of India / London September 25, 2012, 16:15 … a new Harvard study has found. The study upheld the earlier research that showed bein…
Novartis Phase III study in acute heart failure – Pharmacy Europe
TopNews New ZealandNovartis Phase III study in acute heart failurePharmacy EuropePhase III study results show that investigational RLX030 (serelaxin) reduced all-cause mortality in patients with acute heart failure (AHF).[1] The six-month RELAX-AHF stu…
Astellas seeks US FDA approval for tacrolimus ER capsules – pharmabiz.com
Astellas seeks US FDA approval for tacrolimus ER capsulespharmabiz.comAstellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval fo…
Man's Heart Miraculously Heals Itself on Day of Transplant
A miraculous thing happened the day Michael Crowe was set to receive a potentially life-saving heart transplant. Doctors had determined the surgery would be ineffective — but his heart suddenly started beating again. Crowe, a 23-year-old pharmacy stu…
Lindsay Lohan suffering from lung infection? – Times of India
Lindsay Lohan suffering from lung infection?Times of IndiaActor Lindsay Lohan is reportedly suffering from lung infection and she has been taken to hospital after her health worsened. The 26-year-old was not keeping well and telling friends that she su…